Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$3.54
+2.9%
$3.49
$3.07
$6.66
$203.33M0.511.56 million shs971,158 shs
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
$3.64
-22.1%
$3.56
$1.03
$17.18
$53.20M2.57361,993 shs2.45 million shs
Cartesian Therapeutics, Inc. stock logo
RNAC
Cartesian Therapeutics
$8.34
+12.9%
$6.89
$5.60
$15.57
$217.13M0.58192,077 shs278,372 shs
Whitehawk Therapeutics, Inc. stock logo
WHWK
Whitehawk Therapeutics
$4.15
-1.4%
$3.73
$1.55
$4.48
$208.09M0.7211,915 shs147,173 shs
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
+2.91%+7.60%+2.91%+6.95%-23.21%
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
-22.06%-8.08%+10.30%+5.20%+251.01%
Cartesian Therapeutics, Inc. stock logo
RNAC
Cartesian Therapeutics
+12.86%+28.90%+33.65%+32.80%-21.10%
Whitehawk Therapeutics, Inc. stock logo
WHWK
Whitehawk Therapeutics
-1.43%+2.72%+18.57%+53.14%+414,999,900.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$3.54
+2.9%
$3.49
$3.07
$6.66
$203.33M0.511.56 million shs971,158 shs
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
$3.64
-22.1%
$3.56
$1.03
$17.18
$53.20M2.57361,993 shs2.45 million shs
Cartesian Therapeutics, Inc. stock logo
RNAC
Cartesian Therapeutics
$8.34
+12.9%
$6.89
$5.60
$15.57
$217.13M0.58192,077 shs278,372 shs
Whitehawk Therapeutics, Inc. stock logo
WHWK
Whitehawk Therapeutics
$4.15
-1.4%
$3.73
$1.55
$4.48
$208.09M0.7211,915 shs147,173 shs
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
+2.91%+7.60%+2.91%+6.95%-23.21%
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
-22.06%-8.08%+10.30%+5.20%+251.01%
Cartesian Therapeutics, Inc. stock logo
RNAC
Cartesian Therapeutics
+12.86%+28.90%+33.65%+32.80%-21.10%
Whitehawk Therapeutics, Inc. stock logo
WHWK
Whitehawk Therapeutics
-1.43%+2.72%+18.57%+53.14%+414,999,900.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
2.00
HoldN/AN/A
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
2.25
Hold$5.8861.40% Upside
Cartesian Therapeutics, Inc. stock logo
RNAC
Cartesian Therapeutics
2.67
Moderate Buy$34.00307.67% Upside
Whitehawk Therapeutics, Inc. stock logo
WHWK
Whitehawk Therapeutics
2.50
Moderate Buy$7.0068.67% Upside

Current Analyst Ratings Breakdown

Latest HYPD, RNAC, WHWK, and ACB Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/1/2026
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
UpgradeSell (E+)Sell (D-)
5/1/2026
Cartesian Therapeutics, Inc. stock logo
RNAC
Cartesian Therapeutics
Reiterated RatingOutperform$38.00
4/16/2026
Whitehawk Therapeutics, Inc. stock logo
WHWK
Whitehawk Therapeutics
Initiated CoverageOutperform
4/16/2026
Whitehawk Therapeutics, Inc. stock logo
WHWK
Whitehawk Therapeutics
Initiated CoverageMarket Outperform$8.00
4/9/2026
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
UpgradeStrong-Buy
3/30/2026
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
DowngradeHoldStrong Sell
3/27/2026
Cartesian Therapeutics, Inc. stock logo
RNAC
Cartesian Therapeutics
Reiterated RatingSell (E+)
3/27/2026
Whitehawk Therapeutics, Inc. stock logo
WHWK
Whitehawk Therapeutics
Reiterated RatingSell (D-)
3/10/2026
Cartesian Therapeutics, Inc. stock logo
RNAC
Cartesian Therapeutics
Reiterated RatingOutperform$38.00
3/9/2026
Cartesian Therapeutics, Inc. stock logo
RNAC
Cartesian Therapeutics
Reiterated RatingBuy
3/9/2026
Cartesian Therapeutics, Inc. stock logo
RNAC
Cartesian Therapeutics
Reiterated RatingBuy$42.00
(Data available from 5/7/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$246.72M0.85$0.63 per share5.63$7.78 per share0.46
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
$810K51.18N/AN/A$4.73 per share0.77
Cartesian Therapeutics, Inc. stock logo
RNAC
Cartesian Therapeutics
$2.80M87.51N/AN/A($5.04) per share-1.65
Whitehawk Therapeutics, Inc. stock logo
WHWK
Whitehawk Therapeutics
$7.14M28.73N/AN/A$2.89 per share1.44
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$1.63M-$1.08N/AN/AN/A-23.46%-0.04%-0.03%6/17/2026 (Estimated)
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
-$45.31M-$11.80N/A1.71N/AN/A-129.97%-92.39%N/A
Cartesian Therapeutics, Inc. stock logo
RNAC
Cartesian Therapeutics
-$130.30M-$5.90N/AN/AN/A-8,550.65%N/A-28.25%N/A
Whitehawk Therapeutics, Inc. stock logo
WHWK
Whitehawk Therapeutics
-$20.60M$0.478.83N/AN/AN/A-62.88%-58.98%N/A

Latest HYPD, RNAC, WHWK, and ACB Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/30/2026Q1 2026
Cartesian Therapeutics, Inc. stock logo
RNAC
Cartesian Therapeutics
-$0.84-$1.46-$0.62-$1.46$0.22 million$0.08 million
3/26/2026Q4 2025
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
N/A-$7.76N/A-$7.76N/A$0.50 million
3/12/2026Q4 2025
Whitehawk Therapeutics, Inc. stock logo
WHWK
Whitehawk Therapeutics
-$0.55-$0.34+$0.21-$0.34N/AN/A
3/9/2026Q4 2025
Cartesian Therapeutics, Inc. stock logo
RNAC
Cartesian Therapeutics
-$0.82-$1.38-$0.56-$3.57$0.10 million$0.95 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
N/AN/AN/AN/AN/A
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
N/AN/AN/AN/AN/A
Cartesian Therapeutics, Inc. stock logo
RNAC
Cartesian Therapeutics
N/AN/AN/AN/AN/A
Whitehawk Therapeutics, Inc. stock logo
WHWK
Whitehawk Therapeutics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.06
3.06
1.48
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
0.19
2.68
2.68
Cartesian Therapeutics, Inc. stock logo
RNAC
Cartesian Therapeutics
N/A
7.65
7.65
Whitehawk Therapeutics, Inc. stock logo
WHWK
Whitehawk Therapeutics
N/A
10.26
10.26

Institutional Ownership

CompanyInstitutional Ownership
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
47.63%
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
25.84%
Cartesian Therapeutics, Inc. stock logo
RNAC
Cartesian Therapeutics
86.95%
Whitehawk Therapeutics, Inc. stock logo
WHWK
Whitehawk Therapeutics
52.08%

Insider Ownership

CompanyInsider Ownership
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.01%
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
10.86%
Cartesian Therapeutics, Inc. stock logo
RNAC
Cartesian Therapeutics
60.30%
Whitehawk Therapeutics, Inc. stock logo
WHWK
Whitehawk Therapeutics
49.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
1,13059.11 million59.10 millionOptionable
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
4011.39 million10.16 millionNo Data
Cartesian Therapeutics, Inc. stock logo
RNAC
Cartesian Therapeutics
6429.38 million11.67 millionOptionable
Whitehawk Therapeutics, Inc. stock logo
WHWK
Whitehawk Therapeutics
2149.43 million24.76 millionN/A

Recent News About These Companies

Whitehawk Therapeutics Inc.

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Aurora Cannabis stock logo

Aurora Cannabis NASDAQ:ACB

$3.54 +0.10 (+2.91%)
Closing price 05/6/2026 04:00 PM Eastern
Extended Trading
$3.55 +0.01 (+0.28%)
As of 05/6/2026 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Hyperion DeFi stock logo

Hyperion DeFi NASDAQ:HYPD

$3.64 -1.03 (-22.06%)
Closing price 05/6/2026 04:00 PM Eastern
Extended Trading
$3.67 +0.03 (+0.71%)
As of 04:01 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Eyenovia, Inc., an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; and Senju Pharmaceutical Co., Ltd. to develop and commercialize MicroPine, MicroLine, and Mydcombi. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was incorporated in 2014 and is based in New York, New York.

Cartesian Therapeutics stock logo

Cartesian Therapeutics NASDAQ:RNAC

$8.34 +0.95 (+12.86%)
Closing price 05/6/2026 04:00 PM Eastern
Extended Trading
$8.25 -0.09 (-1.13%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, engages in the provision of mRNA cell therapies for the treatment of autoimmune diseases. It develops Descartes-08, an autologous anti-BCMA RNA-engineered chimeric antigen receptor T-cell therapy, currently under Phase 2b clinical development for generalized myasthenia gravis, as well as for patients with systemic lupus erythematosus, and myeloma autoimmune basket trials for other autoimmune diseases. The company develops Descartes-15 to treat Autoimmune diseases, myeloma; and Descartes-33 which is in preclinical development for treatment of autoimmune diseases. Cartesian Therapeutics, Inc. is headquartered in Gaithersburg, Maryland.

Whitehawk Therapeutics stock logo

Whitehawk Therapeutics NASDAQ:WHWK

$4.15 -0.06 (-1.43%)
Closing price 05/6/2026 04:00 PM Eastern
Extended Trading
$4.14 -0.01 (-0.24%)
As of 05/6/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, including tumor agnostic indications targeting specific genomic alterations that activate the mTOR pathway. The company was incorporated in 2007 and is headquartered in Pacific Palisades, California.